文献速递慢性肾脏病肾小球疾病

骨髓失调通过可溶性因子导致肾小球损伤

Dysregulated Bone Marrow Contributes to Glomerular Injury through Soluble Factors.
PubMed 文献 · J Am Soc Nephrol · 2025-08-07

研究从10例CKD患者(8例FSGS,其中6例为肾移植受者)及健康供者获取骨髓,结合体外TNFα暴露髓系生成实验、小鼠模型、斑马鱼滤过功能实验和培养足细胞实验,发现TNFα驱动的骨髓单核细胞改变分泌促炎细胞因子和suPAR,协同导致足细胞骨架紊乱和肾小球滤过功能障碍。

要点

  • CKD患者骨髓TNFα和suPAR水平升高,单核细胞呈炎症转录组特征。
  • TNFα驱动的体外髓系生成产生类似CKD患者的单核细胞,代谢活性增加并分泌促炎细胞因子和suPAR。
  • 这些分泌因子协同导致斑马鱼滤过功能障碍和培养足细胞骨架紊乱,小鼠TNFα暴露增加suPAR和蛋白尿。

核心结论

  • TNFα驱动的骨髓单核细胞改变通过可溶性因子导致CKD中的肾小球功能障碍,提示骨髓功能障碍可能是CKD的核心上游驱动因素。

研究设计与样本

  • 获取10例CKD患者(8例FSGS,其中6例为肾移植受者)及健康供者的骨髓抽吸物,采用ELISA、多重细胞因子检测、多色流式细胞术和单细胞RNA测序分析。
  • 体外髓系生成实验在TNFα暴露下进行,采用ATAC测序、RNA测序、代谢检测、流式细胞术和细胞因子分析评估细胞和分子变化。
  • 在小鼠中测试TNFα阻断以及TNFα与IFNγ共注射的体内效应,并在三种蛋白尿小鼠模型和suPAR缺陷小鼠中测定TNFα水平。
  • 采用培养足细胞的高通量免疫荧光实验和斑马鱼滤过功能实验评估TNFα驱动的功能改变髓系细胞分泌因子对肾功能的影响。

主要发现

  • CKD患者骨髓显示TNFα和suPAR水平升高,单核细胞呈炎症转录组谱。
  • 体外TNFα驱动的髓系生成诱导出类似CKD患者的改变单核细胞,表现为代谢活性增加、转录和表观遗传重编程以及促炎细胞因子和suPAR分泌升高。
  • 这些分泌因子以协同方式导致斑马鱼滤过功能障碍,并引起培养足细胞骨架排列紊乱。
  • 小鼠髓系生成期间TNFα暴露导致suPAR水平升高和蛋白尿。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Patients with CKD show bone marrow alterations, with elevated TNFα and soluble urokinase plasminogen activator receptor (suPAR) levels and proinflammatory monocytic cells. TNFα disrupted myelopoiesis, driving metabolic, transcriptional, and epigenetic changes in monocytes that increased cytokine and soluble urokinase plasminogen activator receptor production. Secreted factors from TNFα-altered myeloid cells synergistically disrupted podocyte structure and glomerular function. BACKGROUND: Immune dysregulation and chronic inflammation have been implicated in the pathogenesis of CKD. Altered bone marrow hematopoiesis is commonly observed in CKD-associated conditions, such as diabetes, cardiovascular disease, and aging. However, the role of bone marrow dysfunction in CKD progression has not been thoroughly interrogated in humans. This study examines how inflammation-induced bone marrow alterations contribute to CKD progression. METHODS: Bone marrow aspirates were obtained from ten patients with CKD (eight with FSGS and six of whom were kidney transplant recipients) and from healthy donors. Samples were analyzed using ELISA, multiplex cytokine assays, multicolor flow cytometry, and single-cell RNA sequencing. To mimic CKD patient bone marrow alterations, in vitro myelopoiesis assays were conducted under TNFα exposure. Cellular and molecular changes were assessed using assay for transposase-accessible chromatin using sequencing, RNA sequencing, metabolic assays, flow cytometry, and cytokine analysis. We tested the in vivo effect of TNFα blockade and coinjection of TNFα with IFNγ in mice. We also measured TNFα levels in three different mouse models of proteinuria and in soluble urokinase plasminogen activator receptor (suPAR)–deficient mice. The effect of secreted factors from TNFα-driven, functionally altered myeloid cells on kidney function was evaluated using high-throughput immunofluorescence assays on cultured podocytes and filtration function assays in zebrafish. RESULTS: Bone marrow from patients with CKD exhibited elevated TNFα and suPAR levels, along with inflammatory transcriptomic profiles in monocytic cells. TNFα-driven myelopoiesis in vitro induced altered monocytic cells resembling those in patients with CKD. These cells displayed increased metabolic activity, transcriptional and epigenetic reprogramming, and elevated secretion of proinflammatory cytokines and suPAR. In a cooperative manner, these secreted factors caused filtration dysfunction in zebrafish and led to cytoskeletal disarrangement in cultured podocytes. In mice, TNFα exposure during myelopoiesis resulted in increased suPAR levels and proteinuria. CONCLUSIONS: TNFα-driven alterations in bone marrow monocytic cells contribute to glomerular dysfunction in CKD, suggesting bone marrow dysfunction as a central upstream driver of CKD. PODCAST: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2025_12_02_ASN0000000828.mp3

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Spear R, Jimenez-Uribe AP, Cao Y, et al. Dysregulated Bone Marrow Contributes to Glomerular Injury through Soluble Factors. J Am Soc Nephrol. 2025. PMID: 40779328. doi:10.1681/ASN.0000000828

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。